Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Pseudomonas
by Most News Heat in the France in 2019

The Pseudomonas top 20 is Discovery PatSnap’ annual ranking of the top 20 Most News Heat Pseudomonas Key Players in the France. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2019, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Pseudomonas is a genus of Gram-negative, Gammaproteobacteria, belonging to the family Pseudomonadaceae and containing 191 validly described species. The members of the genus demonstrate a great deal of metabolic diversity and consequently are able to colonize a wide range of niches. Their ease of culture in vitro and availability of an increasing number of Pseudomonas strain genome sequences has made the genus an excellent focus for scientific research; the best studied species include P. aeruginosa in its role as an opportunistic human pathogen, the plant pathogen P. syringae, the soil bacterium P. putida, and the plant growth-promoting P. fluorescens.
#
Company Name
Region
Tech Topics
Total
1
Medicine,Health care,Antibody,
...[+2]
news: 19
2
Health care,Pharmacy and Therapeutics,Drug,
...[+2]
news: 13
3
news: 13
4
Health care,Poliomyelitis,Typhoid fever,
...[+2]
news: 10
5
Venture capital,Gene delivery,Assets under management,
...[+2]
news: 9
6
Galia Gestion SAS
Venture capital,Asset management
news: 6
7
Phage therapy,Medical equipment,Health care,
...[+2]
news: 6
8
news: 5
9
Venture capital,Investment fund,Financial market,
...[+1]
news: 5
10
IRDI Capital Investissement SAS
Asset management,Alternative investment,Venture capital
news: 5
11
news: 5
12
news: 5
13
Sham Innovation Santé
Gene delivery,Health care,Vehicle control,
...[+2]
news: 5
14
Turenne Capital Partenaires SA
Venture capital,Video game development
news: 4
15
GO Capital SAS
Asset management,Private equity fund,Gene delivery,
...[+2]
news: 4
16
Venture capital,Internationalization,Insulin pump,
...[+2]
news: 4
17
Venture capital,Leveraged buyout,Special situation,
...[+2]
news: 4
18
Venture capital,Industrial biotechnology,Oncogene,
...[+2]
news: 3
19
news: 3
20
Health care,RNA,Molecular medicine,
...[+2]
news: 3
Page generation time: Nov 10 2025